Candel Historical Financial Ratios

CADL Stock  USD 4.71  0.00  0.00%   
Candel Therapeutics is presently reporting on over 91 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.5 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Candel Therapeutics financial condition quickly.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.

About Candel Financial Ratios Analysis

Candel TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Candel Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Candel financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Candel Therapeutics history.

Candel Therapeutics Financial Ratios Chart

At this time, Candel Therapeutics' Tangible Book Value Per Share is quite stable compared to the past year. Shareholders Equity Per Share is expected to rise to 0.46 this year, although the value of Free Cash Flow Yield is projected to rise to (0.78).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Candel Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Candel Therapeutics sales, a figure that is much harder to manipulate than other Candel Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most ratios from Candel Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Candel Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.At this time, Candel Therapeutics' Tangible Book Value Per Share is quite stable compared to the past year. Shareholders Equity Per Share is expected to rise to 0.46 this year, although the value of Free Cash Flow Yield is projected to rise to (0.78).
 2021 2022 2023 2024 (projected)
Current Ratio15.8412.812.592.46
Net Debt To EBITDA3.222.730.340.32

Candel Therapeutics fundamentals Correlations

-0.72-0.430.980.890.48-0.720.960.880.780.44-0.37-0.44-0.03-0.82-1.0-0.28-0.810.23-0.720.8-0.79-0.620.57-0.780.75
-0.720.74-0.81-0.940.041.0-0.88-0.95-0.94-0.81-0.060.920.40.980.77-0.240.990.470.46-0.830.990.94-0.720.99-0.71
-0.430.74-0.5-0.71-0.180.74-0.61-0.72-0.66-0.44-0.30.70.880.730.50.010.710.330.58-0.50.730.52-0.160.72-0.26
0.98-0.81-0.50.950.44-0.810.980.940.890.61-0.39-0.54-0.06-0.89-0.99-0.24-0.880.12-0.620.9-0.86-0.750.7-0.850.85
0.89-0.94-0.710.950.29-0.940.981.00.960.72-0.19-0.74-0.32-0.98-0.93-0.08-0.97-0.13-0.60.91-0.96-0.850.69-0.950.8
0.480.04-0.180.440.290.040.340.260.21-0.08-0.690.380.0-0.09-0.47-0.97-0.050.85-0.370.36-0.030.12-0.010.00.33
-0.721.00.74-0.81-0.940.04-0.88-0.95-0.94-0.81-0.060.920.40.980.77-0.240.990.470.46-0.830.990.94-0.720.99-0.71
0.96-0.88-0.610.980.980.34-0.880.970.90.61-0.23-0.66-0.2-0.95-0.98-0.12-0.94-0.01-0.680.87-0.93-0.780.65-0.920.79
0.88-0.95-0.720.941.00.26-0.950.970.960.72-0.15-0.76-0.34-0.98-0.92-0.04-0.98-0.17-0.60.9-0.97-0.860.69-0.960.79
0.78-0.94-0.660.890.960.21-0.940.90.960.88-0.26-0.76-0.25-0.95-0.83-0.03-0.94-0.23-0.370.97-0.94-0.940.82-0.930.88
0.44-0.81-0.440.610.72-0.08-0.810.610.720.88-0.26-0.71-0.09-0.74-0.490.18-0.75-0.450.10.86-0.75-0.940.92-0.750.84
-0.37-0.06-0.3-0.39-0.19-0.69-0.06-0.23-0.15-0.26-0.26-0.41-0.590.010.340.73-0.01-0.69-0.2-0.5-0.040.12-0.47-0.06-0.64
-0.440.920.7-0.54-0.740.380.92-0.66-0.76-0.76-0.71-0.410.50.860.5-0.570.880.750.36-0.580.890.85-0.550.9-0.44
-0.030.40.88-0.06-0.320.00.4-0.2-0.34-0.25-0.09-0.590.50.360.09-0.110.360.390.43-0.050.390.140.250.380.2
-0.820.980.73-0.89-0.98-0.090.98-0.95-0.98-0.95-0.740.010.860.360.86-0.131.00.320.58-0.851.00.9-0.691.0-0.73
-1.00.770.5-0.99-0.93-0.470.77-0.98-0.92-0.83-0.490.340.50.090.860.260.85-0.180.71-0.830.830.67-0.590.82-0.77
-0.28-0.240.01-0.24-0.08-0.97-0.24-0.12-0.04-0.030.180.73-0.57-0.11-0.130.26-0.17-0.90.17-0.2-0.19-0.280.11-0.22-0.22
-0.810.990.71-0.88-0.97-0.050.99-0.94-0.98-0.94-0.75-0.010.880.361.00.85-0.170.350.57-0.841.00.91-0.71.0-0.73
0.230.470.330.12-0.130.850.47-0.01-0.17-0.23-0.45-0.690.750.390.32-0.18-0.90.35-0.18-0.030.380.49-0.250.40.05
-0.720.460.58-0.62-0.6-0.370.46-0.68-0.6-0.370.1-0.20.360.430.580.710.170.57-0.18-0.280.560.170.090.55-0.13
0.8-0.83-0.50.90.910.36-0.830.870.90.970.86-0.5-0.58-0.05-0.85-0.83-0.2-0.84-0.03-0.28-0.83-0.880.88-0.820.97
-0.790.990.73-0.86-0.96-0.030.99-0.93-0.97-0.94-0.75-0.040.890.391.00.83-0.191.00.380.56-0.830.9-0.681.0-0.71
-0.620.940.52-0.75-0.850.120.94-0.78-0.86-0.94-0.940.120.850.140.90.67-0.280.910.490.17-0.880.9-0.90.91-0.83
0.57-0.72-0.160.70.69-0.01-0.720.650.690.820.92-0.47-0.550.25-0.69-0.590.11-0.7-0.250.090.88-0.68-0.9-0.690.93
-0.780.990.72-0.85-0.950.00.99-0.92-0.96-0.93-0.75-0.060.90.381.00.82-0.221.00.40.55-0.821.00.91-0.69-0.7
0.75-0.71-0.260.850.80.33-0.710.790.790.880.84-0.64-0.440.2-0.73-0.77-0.22-0.730.05-0.130.97-0.71-0.830.93-0.7
Click cells to compare fundamentals

Candel Therapeutics Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Candel Therapeutics is a strong investment it is important to analyze Candel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Candel Therapeutics' future performance. For an informed investment choice regarding Candel Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.73)
Revenue Per Share
0.001
Return On Assets
(0.52)
Return On Equity
(4.81)
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.